Quest Diagnostics Inc. Stock
Quest Diagnostics Inc. Stock
There is an upward development for Quest Diagnostics Inc. compared to yesterday, with an increase of €3.10 (2.010%).
With 8 Buy predictions and not the single Sell prediction the community is currently very high on Quest Diagnostics Inc..
With a target price of 173 € there is a slightly positive potential of 7.82% for Quest Diagnostics Inc. compared to the current price of 160.45 €.
Pros and Cons of Quest Diagnostics Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Quest Diagnostics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Quest Diagnostics Inc. | 2.010% | 5.179% | 3.851% | 6.399% | 7.576% | 17.494% | 55.777% |
| Anthem Inc. | 0.530% | 2.006% | 4.706% | -16.038% | 8.832% | -28.153% | 20.860% |
| HCA Holdings Inc. | -0.410% | 2.060% | -0.412% | 38.498% | 2.085% | 76.556% | 195.827% |
| Universal Health Services B | -1.150% | -3.911% | -9.474% | -3.911% | -10.417% | 27.672% | 56.364% |
Comments
Quest Diagnostics (NYSE:DGX) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics Incorporated (NYSE: DGX) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for DGX provided by MarketBeat